Concepedia

Sara L. Shepheard

SL

20

Publications

1.2K

Citations

16

H-Index

1987

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

University College London

The Royal Free Hospital

University of Leeds

Sara L. Shepheard is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and physiology.

Top concepts

Publications per year

1987–2003

20

Publications

20

Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats

Sara L. Shepheard, David J. Williamson, J. Williams et al. · Neuropharmacology · 1995 · 168 citations

, , +8

The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation

David J. Williamson, Sara L. Shepheard, R.G. Hill et al. · European Journal of Pharmacology · 1997 · 141 citations

, , +6

Possible Antimigraine Mechanisms of Action of the 5HT<sub>1F</sub> Receptor Agonist LY334370

Sara L. Shepheard, Lars Edvinsson, M. Cumberbatch et al. · Cephalalgia · 1999 · 113 citations

, , +22

The non‐peptide neurokinin<sub>1</sub> receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats

Sara L. Shepheard, David J. Williamson, R.G. Hill et al. · British Journal of Pharmacology · 1993 · 104 citations · Full text

, , +18

The anti‐migraine 5‐HT<sub>1B/1D</sub> agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea‐pigs

David J. Williamson, R.G. Hill, Sara L. Shepheard et al. · British Journal of Pharmacology · 2001 · 70 citations · Full text

Rows per page

1–5 of 20